MPWT
AMRX icon

MassMutual Private Wealth & Trust’s Amneal Pharmaceuticals AMRX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3K Hold
652
– – ﹤0.01% 1352
2026
Q1 		$8.1K Hold
652
– – ﹤0.01% 1452
2025
Q4 		$8.21K Hold
652
– – ﹤0.01% 1473
2025
Q3 		$6.53K Buy
652
+284
+77% +$2.55K ﹤0.01% 1573
2025
Q2 		$2.98K Sell
368
-136
-27% -$1.02K ﹤0.01% 1827
2025
Q1 		$4.22K Buy
504
+380
+306% +$3.17K ﹤0.01% 1663
2024
Q4 		$982 Buy
+124
New +$1.04K ﹤0.01% 2024
2018
Q3 		– Sell
-52
Closed -$853 – 972
2018
Q2 		$853 Buy
+52
New +$913 ﹤0.01% 1026

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

MassMutual Private Wealth & Trust's AMRX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 652 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1352.

MassMutual Private Wealth & Trust first reported a position in AMRX in Q2 2018 and has held it in 8 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • MassMutual Private Wealth & Trust held 652 shares of Amneal Pharmaceuticals worth $11.3K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1352 holding.
  • MassMutual Private Wealth & Trust first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 8 quarters since.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.